The diastereoisomers methyl 5‐(S)‐[2‐(R)/(S)‐methoxycarbonyl)‐2,3,4,5‐tetrahydropyrrol‐1‐ylcarbonyl]‐1‐(4‐methylphenyl)‐4,5‐dihydropyrazole‐3‐carboxylate

The title diastereoisomers, methyl 5‐(S)‐[2‐(S)‐methoxy­carbonyl)‐2,3,4,5‐tetra­hydro­pyrrol‐1‐yl­carbonyl]‐1‐(4‐methyl­phenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxyl­ate and methyl 5‐(S)‐[2‐(R)‐methoxycarbonyl)‐2,3,4,5‐tetrahydropyrrol‐1‐ylcarbonyl]‐1‐(4‐methyl­phenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxylate, both C₁₉H₂₃N₃O₅, have been studied in two crystalline forms. The first form, methyl 5‐(S)‐[2‐(S)‐methoxy­carbonyl)‐2,3,4,5‐tetrahydropyrrol‐1‐ylcarbonyl]‐1‐(4‐methylphenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxyl­ate–methyl 5‐(S)‐[2‐(R)‐methoxy­carbonyl)‐2,3,4,5‐tetra­hydro­pyrrol‐1‐yl­carbonyl]‐1‐(4‐methylphenyl)‐4,5‐dihydropyrazole‐3‐carboxylate (1/1), 2(S),5(S)‐C₁₉H₂₃N₃O₅·2(R),5(S)‐C₁₉H₂₃N₃O₅, contains both S,S and S,R isomers, while the second, methyl 5‐(S)‐[2‐(S)‐methoxycarbonyl)‐2,3,4,5‐tetrahydro­pyrrol‐1‐ylcarbonyl]‐1‐(4‐methyl­phenyl)‐4,5‐di­hydro­pyrazole‐3‐carboxyl­ate, 2(S),5(S)‐C₁₉H₂₃N₃O₅, is the pure S,S isomer. The S,S isomers in the two structures show very similar geometries, the maximum difference being about 15° on one torsion angle. The differences between the S,S and S,R isomers, apart from those due to the inversion of one chiral centre, are more remarkable, and are partially due to a possible rotational disorder of the 2‐­(methoxycarbonyl)tetrahydropyrrole group.     

20‐Di­cyano­methyl­ene‐5,8,11,14‐tetraoxa‐2,17‐di­thia­bi­cyclo­[16.4.1]­tricosa‐1(23),18,21‐triene and its mercury(II) dichloride complex

The structures of the title compound, C₂₀H₂₄N₂O₄S₂, and its mercury(II) dichloride complex, dichloro{20‐di­cyano­methyl­ene‐5,8,11,14‐tetraoxa‐2,17‐di­thia­bi­cyclo­[16.4.1]­tricosa‐1(23),18,­21‐tri­ene‐κ⁴O,κS¹⁷}mercury(II), [HgCl₂(C₂₀­H₂₄­N₂­O₄­S₂)], have been determined by X‐ray crystallographic analyses. The mercury(II) dichloride complex has two independent mol­ecules of [HgCl₂(C₂₀H₂₄N₂O₄S₂)] in the lattice. The mercury(II) ion has pentagonal bipyramidal coordination which involves one S atom, four O atoms and two Cl^? ions.     

2′,3′‐Dehydrosalannol

The title compound, methyl (2aS,3R,5R,5aS,6S,6aS,8R,9aS,10aR,10bR,10cS)‐8‐(3‐furyl)‐2a,4,5,5a,6,6a,8,9,9a,10a,10b,10c‐dodeca­hydro‐3‐hydroxy‐2a,5a,6a,7‐tetra­methyl‐5‐(3‐methylbut‐2‐enoyl­oxy)‐2H,3H‐cyclo­penta­[4′,5′]­furo­[2′,3′:6,5]benzo[cd]­isobenzo­furan‐6‐acetate, C₃₂H₄₂O₈, was isolated from uncrushed green leaves of Azadirachta indica A. Juss (neem) and has been found to possess antifeedant activity against Spodptera litura. The conformations of the functional groups are similar to those of 3‐des­acetyl­salannin, which was isolated from neem kernels. The mol­ecules are linked into chains by intermolecular O—H?O hydrogen bonds.     

3β,7α,12α‐Tri­formyl­oxy‐24‐nor‐5β‐chol‐22‐ene

The title compound, alternatively called 24‐nor‐5β‐chol‐22‐ene‐3β,7α,12α‐triyl triformate, C₂₆H₃₈O₆, has a cis junction between two of the six‐membered rings. All three of the six‐membered rings have chair conformations that are slightly flattened and the five‐membered ring has a 13β,14α‐half‐chair conformation. The 3β, 7α and 12α ring substituents are axial and the 17β group is equatorial. The 3β‐formyl­oxy group is involved in one weak intermol­ecular C—H⋯O bond, which links the mol­ecules into dimers in a head‐to‐head fashion.     

2‐{[Tris(hydroxymethyl)methyl]aminomethylene}cyclohexa‐3,5‐dien‐1(2H)‐one and its 6‐hydroxy and 6‐methoxy derivatives

The title compounds, 2‐{[tris­(hydroxy­methyl)­methyl]­amino­methyl­ene}cyclo­hexa‐3,5‐dien‐1(2H)‐one, C₁₁H₁₅NO₄, (I), 6‐hydroxy‐2‐{[tris­(hydroxy­methyl)­methyl]­amino­methyl­ene}­cyclo­hexa‐3,5‐dien‐1(2H)‐one, C₁₁H₁₅NO₅, (II), and 6‐methoxy‐2‐{[tris­(hydroxy­methyl)­methyl]­amino­methyl­ene}­cyclo­hexa‐3,5‐dien‐1(2H)‐one, C₁₂H₁₇NO₅, (III), adopt the keto–amine tautomeric form, with the formal hydroxy H atom located on the N atom, and the NH group and oxo O atom display a strong intramolecular N—H⋯O hydrogen bond. The N—H⋯O hydrogen‐bonded rings are almost planar and coupled with the cyclo­hexa­diene rings. The carbonyl O atoms accept two other H atoms from the alcohol groups of adjacent mol­ecules in (I), and one from the alcohol and one from the phenol group in (II), but from only one alcohol H atom in (III).     

Precursors to dodecahedrane

The title compounds, (2R,2′′S,3b′S,4a′R,7b′S,8a′R)‐per­hydro­di­spiro­[furan‐2,3′‐di­cyclo­penta­[a,e]­pentalene‐7′,2′′‐furan]‐5,5′′‐dione, C₂₀H₂₆O₄, and (3aR,3bR,4aR,4bS,5aS,8aR,8bR,9aR,9bS,10aS)‐per­hydro­dipentaleno­[2,1‐a:2′,1′‐e]­pentalene‐1,6‐dione, C₂₀H₂₆O₂, are intermediates identified during the synthesis of dodecahedrane. Crystallographic studies have established the ring‐junction stereochemistry for these important intermediates. All the ring junctions are cis‐fused, and the molecular packing is stabilized by van der Waals interactions.     

10‐(4‐Fluorophenyl)‐3,3,6,6,9‐pentamethyl‐3,4,6,7,9,10‐hexahydroacridine‐1,8(2H,5H)‐dione and 10‐(4‐fluorophenyl)‐3,3,6,6‐tetramethyl‐9‐­propyl‐3,4,6,7,9,10‐hexahydroacridine‐1,8(2H,5H)‐dione

10‐(4‐Fluoro­phenyl)‐3,3,6,6,9‐penta­methyl‐3,4,6,7,9,10‐hexa­hydro­acridine‐1,8(2H,5H)‐dione, C₂₄H₂₈FNO₂, (I), crystallizes with two crystallographically independent mol­ecules (which differ slightly in conformation), while 10‐(4‐fluoro­phenyl)‐9‐propyl‐3,3,6,6‐tetra­methyl‐3,4,6,7,9,10‐hexa­hydro­acridine‐1,8(2H,5H)‐dione, C₂₆H₃₂FNO₂, (II), crystallizes with one mol­ecule per asymmetric unit. In both structures, the central ring in the acridine moiety is in a sofa conformation, while the outer rings adopt intermediate half‐chair/sofa conformations. The central pyridine ring is orthogonal to the substituted phenyl ring. In both structures, the packing of the crystal is stabilized by C—H?O intermolecular hydrogen bonds.     

5‐Fluoro‐1‐octanoyl­uracil

The crystal structure of 5‐fluoro‐1‐octanoyl­uracil [5‐fluoro‐1‐octanoyl­pyrimidine‐2,4(1H,3H)‐dione, C₁₂H₁₇FN₂O₃], a lipophilic prodrug of 5‐fluoro­uracil, is described. The 5‐fluoro­pyrimidine‐2,4(1H,3H)‐dione moiety is similar to the known structure of 1‐acetyl‐5‐fluoro­uracil. The 1‐octanoyl group and the 5‐fluoro­uracil moiety are essentially coplanar, with the octanoyl carbonyl group oriented towards the the ring C—H group and away from the nearer ring carbonyl group. The torsion angle C—N—C—O (from the ring CH group to the octanoyl carbonyl group) of 9.2 (2)° is similar to the corresponding torsion angles reported for 1‐acetyl‐5‐fluoro­uracil (17.3 and 1.6°) and 1,3‐di­acetyl‐5‐fluoro­uracil (8.8°).     

The α‐ and β‐epoxides of 3β‐acet­oxy‐5α‐lanost‐9(11)‐en‐7‐one

The structures of 3β‐acet­oxy‐9α,11α‐ep­oxy‐5α‐lanost‐9(11)‐en‐7‐one and 3β‐acet­oxy‐9β,11β‐ep­oxy‐5α‐lanost‐9(11)‐en‐7‐one, C₃₂H₅₂O₄, differ in their respective substituted cyclo­hexa­none rings but adopt similar conformations in the other three rings. In both of the crystal structures, weak inter­molecular C—H⋯O inter­actions are present.     

New electron‐deficient chiral phosphines: (4R,5R)‐1,3‐bis(trifluoromethanesulfonyl)perhydro‐1,3,2‐benzodiazaphosphol‐2‐yl] substituted amines

Three chiral electron‐deficient phosphine ligands, [(4R,15R)‐,3‐bis­(tri­fluoro­methane­sulfonyl)­per­hydro‐1,3,2‐benzodiazaphosphol‐2‐yl]­diethyl­amine, C₁₂H₂₀F₆N₃O₄PS₂, (IIIa), [(4R,5R)‐1,3‐bis­(tri­fluoro­methane­sulfonyl)­per­hydro‐1,3,2‐benzodi­aza­phosphol‐2‐yl]­di­methyl­amine, C₁₀H₁₆F₆N₃O₄PS₂, (IIIb), and bis­[(4R,5R)‐1,3‐bis­(tri­fluoro­methane­sulfonyl)­per­hydro‐1,3,2‐benzodi­aza­phosphol‐2‐yl]­methyl­amine, (IV), as the chloroform solvate, C₁₇H₂₃F₁₂N₅O₈P₂S₄·0.98CHCl₃, have been prepared from (1R,2R)‐N,N′‐bis­(tri­fluoro­methane­sulfonyl)‐1,2‐cyclo­hexane­di­amine and diethyl phosphor­amido­us dichloride, dimethyl phosphoramidous dichloride or methyl imidodi­phosphorus tetrachloride. The π‐acceptor abilities of these new types of ligands have been evaluated by X‐ray determination of the P—N bond lengths; it has been found that the most promising ligand is the bis­(phosphine) (IV).     

A pair of epimeric 13‐hydroxy‐2,3,6,7‐tetra­methoxy‐8b,11,12,12a,13,13a‐hexa­hydro‐9H‐9a‐aza­cyclo­penta­[b]tri­phenyl­ene‐10‐ones

The structures of two compounds which are intermediates in the synthesis of phenanthroindolizidine alkaloids have been determined. (8bS,13aS,14R,14aR)‐8b,9,11,12,13,13a,14,14a‐Octa­hydro‐14‐hydroxy‐2,3,6,7‐tetra­methoxy­dibenzo­[f,h]pyrrolo[1,2‐b]­isoquinolin‐11‐one acetone solvate, C₂₄H₂₇NO₆·C₃H₆O, (II), crystallizes in a chiral space group with one solvent mol­ecule (acetone) present in the asymmetric unit. On the other hand, (8bS,13aS,14S,14aR)‐8b,9,11,12,13,13a,14,14a‐octa­hydro‐14‐hydroxy‐2,3,6,7‐tetra­methoxy­dibenzo­[f,h]pyrrolo[1,2‐b]­isoquinolin‐11‐one, C₂₄H₂₇NO₆, (III), crystallizes in a centrosymmetric space group with two mol­ecules in the asymmetric unit and with no solvent present. The two mol­ecules in the asymmetric unit of (III) are structurally the same. Compounds (II) and (III) are epimers at the C atom carrying the OH group; otherwise they are very similar in structure.     

A steroidal phenyldi­hydro‐1,3‐oxazine derivative

The structure of methyl (6R)‐6‐(3′β‐acetoxy‐5′‐androsten‐17′β‐yl)‐2‐phenyl‐5,6‐dihydro‐4H‐[1,3]oxazine, C₃₁H₄₁NO₃, synthesized from an azidopregnene derivative, is reported. The di­hydro‐1,3‐oxazine ring is connected in the β position to the sterane skeleton at C‐17′. An R configuration was found at C‐6.     

Racemic and chiral 1‐[N‐(chloro­acetyl)carbamoylamino]‐2,3‐dihydro‐1H‐inden‐2‐yl chloroacetate

In the racemic crystals of (1S,2R)‐ or (1R,2S)‐1‐[N‐(chloro­acetyl)­carbamoyl­amino]‐2,3‐di­hydro‐1H‐inden‐2‐yl chloro­acetate, C₁₄H₁₄Cl₂N₂O₄, (I), the enantiomeric mol­ecules form a dimeric structure via the N—H?O cyclic hydrogen bond of the carbamoyl moieties. In the chiral crystals of (—)‐(1S,2R)‐1‐[N‐(chloro­acetyl)­carbamoyl­amino]‐2,3‐di­hydro‐1H‐inden‐2‐yl chloro­acetate, C₁₄H₁₄Cl₂N₂O₄, (II), the N—­H?O intermolecular hydrogen bond forms a zigzag chain around the twofold screw axis. The melting points and calculated densities of (I) and (II) are 446 and 396 K, and 1.481 and 1.445 Mg m^?3, respectively.     

2‐[2‐Methyl‐5‐nitro‐4‐(phenyl­sulfonyl­methyl)­imidazol‐1‐yl]­ethanol and 2‐methyl‐5‐nitro‐4‐phenyl­sulfonyl­methyl‐1,3‐thia­zole

The title compounds, C₁₃H₁₅N₃O₅S and C₁₁H₁₀N₂O₄S₂, respectively, both contain a phenyl­sulfonyl group connected, through a methyl­ene bridge, to either a substituted nitro­imidazole or nitro‐1,3‐thia­zole ring. In the imidazole‐containing mol­ecule, the nitro and sulfonyl groups are trans relative to the sulfonyl–methyl bond, while in the thia­zole‐containing mol­ecule, these substituents are cis. The stabilizing interactions within the crystals are also different between the two compounds.     

Precursor of a β‐lactamase inhibitor: allyl (4S,8S,9R)‐10‐[(E)‐ethyl­idene]‐4‐methoxy‐11‐oxo‐1‐aza­tri­cyclo­[7.2.0.03,8]­undec‐2‐ene‐2‐carboxyl­ate

The molecular structure of the title tricyclic compound, C₁₇H₂₁NO₄, which is the immediate precursor of a potent synthetic inhibitor {Lek157: sodium (8S,9R)‐10‐[(E)‐ethyl­idene]‐4‐methoxy‐11‐oxo‐1‐aza­tri­cyclo­[7.2.0.0^3,8]­undec‐2‐ene‐2‐carboxyl­ate} with remarkable potency, provides experimental evidence for the previously modelled relative position of the fused cyclo­hexyl ring and the carbonyl group of the β‐lactam ring, which takes part in the formation of the initial tetrahedral acyl–enzyme complex. In this hydro­phobic mol­ecule, the overall geometry is influenced by C—H?O intramolecular hydrogen bonds [3.046 (4) and 3.538 (6) Å, with corresponding normalized H?O distances of 2.30 and 2.46 Å], whereas the mol­ecules are interconnected through intermolecular C—H?O hydrogen bonds [3.335 (4)–3.575 (5) Å].     

Revisiting the absolute chirality and polymorphism of (–)‐Istanbulin A

The terpenoid (?)‐Istanbulin A is a natural product isolated from Senecio filaginoides DC, one of the 270 species of Senecio (Asteraceae) which occurs in Argentina. The structure and absolute configuration of this compound [9a‐hydroxy‐3,4a,5‐trimethyl‐4a,6,7,8a,9,9a‐hexahydro‐4H,5H‐naphtho[2,3‐b]‐furan‐2,8‐dione or (4S,5R,8R,10S)‐1‐oxo‐8β‐hydroxy‐10βH‐eremophil‐7(11)‐en‐12,8β‐olide, C₁₅H₂₀O₄] were determined by single‐crystal X‐ray diffraction studies. It proved to be a sesquiterpene lactone showing an eremophilanolide skeleton whose chirality is described as 4S,5R,8R,10S. Structural results were also in agreement with the one‐ and two‐dimensional (1D and 2D) NMR and HR–ESI–MS data, and other complementary spectroscopic information. In addition, (?)‐Istanbulin A is a polymorph of the previously reported form of (?)‐Istanbulin A, form I; thus, the title compound is denoted form II or polymorph II. Structural data and a literature search allowed the chirality of Istanbulin A to be revisited. The antimicrobial and antifungal activities of (?)‐Istanbulin A, form II, were evaluated in order to establish a reference for future comparisons and applications related to specific crystal forms of Istanbulins.     

Three new dihydro‐β‐agarofuran sesquiterpenes from the seeds of Maytenus boaria

As part of a project studying the secondary metabolites extracted from the Chilean flora, we report herein three new β‐agarofuran sesquiterpenes, namely (1S,4S,5S,6R,7R,8R,9R,10S)‐6‐acetoxy‐4,9‐dihydroxy‐2,2,5a,9‐tetramethyloctahydro‐2H‐3,9a‐methanobenzo[b]oxepine‐5,10‐diyl bis(furan‐3‐carboxylate), C₂₇H₃₂O₁₁, ( II ), (1S,4S,5S,6R,7R,9S,10S)‐6‐acetoxy‐9‐hydroxy‐2,2,5a,9‐tetramethyloctahydro‐2H‐3,9a‐methanobenzo[b]oxepine‐5,10‐diyl bis(furan‐3‐carboxylate), C₂₇H₃₂O₁₀, ( III ), and (1S,4S,5S,6R,7R,9S,10S)‐6‐acetoxy‐10‐(benzoyloxy)‐9‐hydroxy‐2,2,5a,9‐tetramethyloctahydro‐2H‐3,9a‐methanobenzo[b]oxepin‐5‐yl furan‐3‐carboxylate, C₂₉H₃₄O₉, ( IV ), obtained from the seeds of Maytenus boaria and closely associated with a recently published relative [Paz et al. (2017). Acta Cryst. C 73 , 451–457]. In the (isomorphic) structures of ( II ) and ( III ), the central decalin system is esterified with an acetate group at site 1 and furoate groups at sites 6 and 9, and differ at site 8, with an OH group in ( II ) and no substituent in ( III ). This position is also unsubstituted in ( IV ), with site 6 being occupied by a benzoate group. The chirality of the skeletons is described as 1S,4S,5S,6R,7R,8R,9R,10S in ( II ) and 1S,4S,5S,6R,7R,9S,10S in ( III ) and ( IV ), matching the chirality suggested by NMR studies. This difference in the chirality sequence among the title structures (in spite of the fact that the three skeletons are absolutely isostructural) is due to the differences in the environment of site 8, i.e. OH in ( II ) and H in ( III ) and ( IV ). This diversity in substitution, in turn, is responsible for the differences in the hydrogen‐bonding schemes, which is discussed.     

Cocrystallization and configurations of myo‐inositol‐1,2‐l‐camphor acetals in two crystal structures

The inositol rings in (1S,2R,3R,4S,5S,6R,7S,8S,11S)‐myo‐inositol‐1,2‐camphor acetal {systematic name: (1R,2S,3S,4R,5S,6R)‐5,6‐[(1S,2S,4S)‐1,7,7‐trimethyl­bicyclo­[2.2.1]heptane‐2,2‐diyldi­oxy]cyclohexane‐1,2,3,4‐tetrol}, C₁₆H₂₆O₆, and (1R,2S,3S,4R,5R,6S,7R/S,8S,11S)‐myo‐inositol‐1,2‐camphor acetal trihydrate {systematic name: (1S,2R,3R,4S,5R,6S)‐5,6‐[(1S,4S,6R/S)‐1,7,7‐trimethyl­bicyclo­[2.2.1]heptane‐2,2‐diyldi­oxy]cyclohexane‐1,2,3,4‐tetrol trihydrate}, C₁₆H₂₆O₆·3H₂O, adopt flattened chair conformations with the latter crystal containing two stereoisomers in a 0.684 (2):0.316 (2) ratio, similar to that found both in solution and by calculation. Both mol­ecules pack in the crystals in similar two‐dimensional layers, utilizing strong O—H⋯O hydrogen bonds, with the trihydrate cell expanded to incorporate the additional hydrogen‐bonded water mol­ecules.     

Retroracemization using new forms of Belokon's original ligand: ­intermediate NiII complexes of N‐({2‐[N‐(S)‐alkylprolylamino]phenyl}phenylmethylene)‐(S)‐phenylalanine (alkyl is 2‐picolyl, 3‐picolyl or ethyl)

In the title compounds, [N‐(phenyl{2‐[N‐(S)‐(2‐picolyl)­prolyl­amino]­phenyl}methyl­ene)‐(S)‐phenyl­alaninato]­nickel(II), [Ni(C₃₃H₃₀N₄O₃)], (I), [N‐(phenyl{2‐[N‐(S)‐(3‐picolyl)­prolyl­amino]­phenyl}methyl­ene)‐(S)‐phenyl­alaninato]­nickel(II) hemihydrate, [Ni(C₃₃H₃₀N₄O₃)]·0.5H₂O, (II), and [N‐({2‐[N‐(S)‐ethyl­prolyl­amino]­phenyl}phenyl­methyl­ene)‐(S)‐phenyl­ala­nin­ato]­nickel(II), [Ni(C₂₉H₂₉N₃O₃)], (III), the Ni^II centres have approximate square‐planar coordination geometries from N₃O donor sets. The picolyl N atoms in (I) and (II) are too remote from the metal centres to interact significantly, but the metal coordination geometries experience tetrahedral distortion and/or displacement of the metal centre from the N₃O plane. These are linked to conformational differences between the ligands of the symmetry‐independent complexes (Z′ = 2), which in turn are related to molecular packing. In (III), where a less sterically demanding ethyl group replaces the picolyl substituents, there are none of the distortions or displacements seen in (I) and (II).